|
FAM8A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62569957495862E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.53761505936745E-14 |
| Normal-vs-Stage2 |
1.80180000000085E-05 |
| Normal-vs-Stage3 |
1.16018306073329E-13 |
| Normal-vs-Stage4 |
3.79341003053923E-12 |
| Stage1-vs-Stage2 |
2.031200E-01 |
| Stage1-vs-Stage3 |
8.910200E-02 |
| Stage1-vs-Stage4 |
4.179600E-02 |
| Stage2-vs-Stage3 |
2.698400E-02 |
| Stage2-vs-Stage4 |
1.172070E-02 |
| Stage3-vs-Stage4 |
5.056200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.964600E-03 |
| Normal-vs-Asian |
6.2505001174884E-11 |
| Caucasian-vs-AfricanAmerican |
1.552150E-01 |
| Caucasian-vs-Asian |
8.777800E-01 |
| AfricanAmerican-vs-Asian |
1.572410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.87987469613927E-13 |
| Normal-vs-Female |
1.64934732538313E-12 |
| Male-vs-Female |
8.437000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.07596179030634E-12 |
| Normal-vs-Age(41-60Yrs) |
2.72315503480058E-12 |
| Normal-vs-Age(61-80Yrs) |
6.84019507701805E-12 |
| Normal-vs-Age(81-100Yrs) |
1.043710E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.921600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.871200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.605400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.136200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.729000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.122400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.64570000000298E-05 |
| Classical-VS-Follicular |
3.255700E-02 |
| Classical-VS-Other |
7.662000E-01 |
| Classical-VS-Normal |
1.63768998362457E-12 |
| Tall-VS-Follicular |
1.12210000002833E-06 |
| Tall-VS-Other |
1.048840E-01 |
| Tall-VS-Normal |
1.3988810110277E-14 |
| Follicular-VS-Other |
3.542600E-01 |
| Follicular-VS-Normal |
1.90170999999628E-05 |
| Other-VS-Normal |
2.561400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.4317992064482E-11 |
| Normal-vs-N1 |
1.51001433579268E-12 |
| N0-vs-N1 |
4.665800E-02 |
|
|
